Share Email Print

Proceedings Paper

Contact laser vaporization of the prostate for benign prostatic hypertrophy
Author(s): Leonard G. Gomella M.D.; M. Amr Lotfi; Douglas F. Milam M.D.; David Albala M.D.; Gary Reagan M.D.
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The contact laser applications for the removal of the enlarged prostate are distinctly different than the majority of non-contact Nd:YAG lasers that rely on coagulation necrosis and delayed sloughing. Contact Nd:YAG laser allows cutting, coagulation and vaporization of tissue with minimal penetration beyond the contact surface. Using the contact laser prostatectomy technique, the contact laser probe directly touches and immediately vaporizes the prostatic tissue under the probe. The net result is the immediate removal of the obstructing tissue, in a manner similar to the standard electrosurgical TURP. This immediate removal of tissue offers the patient treated with the contact laser the potential for decreased catheter time and a more rapid resolution of symptoms. Our initial experience suggests that the contact technique may be better suited for the smaller prostate gland (i.e. less than 30 gm). The contact laser may also be used for a procedure termed the `laser assisted TURP': a standard electrosurgical TURP is performed and the contact laser is used for hemostasis. Several investigators have reported non-randomized results of the contact technique with good outcomes. A prospective randomized trial of the contact laser prostatectomy vrs the electrosurgical TURP is underway. The contact laser vaporization of the prostate holds great promise for the treatment of symptomatic benign prostatic hypertrophy: it is virtually bloodless and allows immediate visualization of the TUR defect.

Paper Details

Date Published: 2 May 1994
PDF: 7 pages
Proc. SPIE 2129, Lasers in Urology, (2 May 1994); doi: 10.1117/12.175023
Show Author Affiliations
Leonard G. Gomella M.D., Thomas Jefferson Univ. (United States)
M. Amr Lotfi, Thomas Jefferson Univ. (United States)
Douglas F. Milam M.D., Vanderbilt Univ. (United States)
David Albala M.D., Loyola Univ. (United States)
Gary Reagan M.D., Crossroads Community Hospital (United States)

Published in SPIE Proceedings Vol. 2129:
Lasers in Urology
Graham M. Watson M.D.; Rudolf W. Steiner; Douglas E. Johnson M.D., Editor(s)

© SPIE. Terms of Use
Back to Top